The Burden of Dialysis-Related Symptoms and Medication Non-Adherence Among Patients on Peritoneal Dialysis in Oman: A Multi-Center Study

Background: Patients on Peritoneal Dialysis (PD) experience substantial dialysis-related symptoms and medication non-adherence that negatively impact clinical outcomes, yet these remain understudied in Oman and other Middle East countries. Objectives: To determine the prevalence of dialysis-related symptoms and assess medication adherence among Omani adult patients on PD. Methods: A descriptive cross-sectional correlational study was conducted among 185 Omani adults receiving PD, recruited using stratified random sampling from government hospitals across Oman. Data were collected using a self-administered questionnaire comprising the researcher-developed Peritoneal Dialysis Symptoms and Life Impact Scale (PD-SLIS; Cronbach’s α = 0.97) and the Arabic version of the Adherence to Refills and Medications Scale (ARMS; Cronbach’s α = 0.71). Data were analyzed using descriptive statistics, chi-square tests, and multiple logistic regression. Results: The participants’ mean age was 51.54 ± 14.92 years, and 50.3% were female. The mean total symptom burden score was 82.56 ± 54.60. The most prevalent symptoms were limitations in general activities (85.9%), mood changes (85.9%), lack of energy (82.7%), and weakness (81%). All the 34 assessed symptoms were reported by ≥47% of the participants. Most participants (66.5%) reported low medication adherence (mean ARMS score = 19.73 ± 5.42). Regression analysis identified age (OR = 1.04, p = 0.02), high school education (OR = 4.68, p < 0.01), and daily number of medications (OR = 0.89, p = 0.04) as significant independent predictors of medication adherence. Conclusions: Omani patients on PD experience a pervasive symptom burden alongside predominantly low medication adherence. Routine symptom screening using the PD-SLIS, polypharmacy reduction strategies, and adherence interventions are recommended as standard components of PD clinical practice in Oman and other settings with similar contexts.

Authors

Institutions

Publication Details

Journal
Kidney and Dialysis
Published
2026-08-24
DOI
https://doi.org/10.3390/kidneydial6030057
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Burden of Dialysis-Related Symptoms and Medication Non-Adherence Among Patients on Peritoneal Dialysis in Oman: A Multi-Center Study

Omar Al Zaabi, Eilean Rathinasamy Lazarus, Joshua Kanaabi Muliira, Ibtisam Al Saidi
Kidney and Dialysis
Dialysis and Renal Disease Management
article

The Burden of Dialysis-Related Symptoms and Medication Non-Adherence Among Patients on Peritoneal Dialysis in Oman: A Multi-Center Study

Omar Al Zaabi, Eilean Rathinasamy Lazarus, Joshua Kanaabi Muliira, Ibtisam Al Saidi
article en

Abstract

Background: Patients on Peritoneal Dialysis (PD) experience substantial dialysis-related symptoms and medication non-adherence that negatively impact clinical outcomes, yet these remain understudied in Oman and other Middle East countries. Objectives: To determine the prevalence of dialysis-related symptoms and assess medication adherence among Omani adult patients on PD. Methods: A descriptive cross-sectional correlational study was conducted among 185 Omani adults receiving PD, recruited using stratified random sampling from government hospitals across Oman. Data were collected using a self-administered questionnaire comprising the researcher-developed Peritoneal Dialysis Symptoms and Life Impact Scale (PD-SLIS; Cronbach’s α = 0.97) and the Arabic version of the Adherence to Refills and Medications Scale (ARMS; Cronbach’s α = 0.71). Data were analyzed using descriptive statistics, chi-square tests, and multiple logistic regression. Results: The participants’ mean age was 51.54 ± 14.92 years, and 50.3% were female. The mean total symptom burden score was 82.56 ± 54.60. The most prevalent symptoms were limitations in general activities (85.9%), mood changes (85.9%), lack of energy (82.7%), and weakness (81%). All the 34 assessed symptoms were reported by ≥47% of the participants. Most participants (66.5%) reported low medication adherence (mean ARMS score = 19.73 ± 5.42). Regression analysis identified age (OR = 1.04, p = 0.02), high school education (OR = 4.68, p < 0.01), and daily number of medications (OR = 0.89, p = 0.04) as significant independent predictors of medication adherence. Conclusions: Omani patients on PD experience a pervasive symptom burden alongside predominantly low medication adherence. Routine symptom screening using the PD-SLIS, polypharmacy reduction strategies, and adherence interventions are recommended as standard components of PD clinical practice in Oman and other settings with similar contexts.

Kidney and DialysisVol. 6(3)
College of Applied Sciences- Ibri (OM), Sultan Qaboos University (OM)
Openalex Percentile: Top 10%
Dialysis and Renal Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.